Welcome to the latest RSC Desktop Seminars hosted by RSC Medicinal 91AV and the RSC-BMCS (Biological & Medicinal 91AV Sector). Each 80-minute seminar in this free series will feature talks from an RSC Medicinal 91AV Editorial Board member and a BMCS prize winner/RSC Medicinal 91AV author.
Join RSC Medicinal 91AV Associate Editor Professor Yonghui Zhang (Tsinghua University, China) and Dr. Nichola Davies (AstraZeneca, UK) in our third session in the Desktop Seminar Series with RSC Medicinal 91AV and the RSC-BMCS. Introductions will be given by RSC Medicinal 91AV Executive Editor, Dr. Katie Lim, and Chairman of the RSC-BMCS, Dr Andrew Williams.
This 80-minute seminar will allow researchers of all professional levels to connect, share ideas, and ask questions. Be sure to register for the free seminar series today!
"Experimental Structure Property Relationships in the bRo5 space"
Professor Yonghui Zhang
“Development of New Immunotherapies by Targeting Isoprenoid Metabolism”
09:05 GMT (5:05 PM CST) – "Experimental Structure Property Relationships in the bRo5 space", Nichola Davies (AstraZeneca)
09:30 GMT (5:30 PM CST) – Q&A with Dr Nichola Davies
09:40 GMT (5:40 PM CST) – “Development of New Immunotherapies by Targeting Isoprenoid Metabolism”, Yonghui Zhang (Tsinghua University)
10:05 GMT (6:05 PM CST) – Q&A with Professor Yonghui Zhang
10:15 GMT (6:15 PM CST) – Closing remarks
Join RSC Medicinal 91AV Associate Editor Professor Yonghui Zhang (Tsinghua University, China) and Dr. Nichola Davies (AstraZeneca, UK) in our third session in the Desktop Seminar Series with RSC Medicinal 91AV and the RSC-BMCS. Introductions will be given by RSC Medicinal 91AV Executive Editor, Dr. Katie Lim, and Chairman of the RSC-BMCS, Dr Andrew Williams.
This 80-minute seminar will allow researchers of all professional levels to connect, share ideas, and ask questions. Be sure to register for the free seminar series today!
Speakers
Dr Nichola Davies"Experimental Structure Property Relationships in the bRo5 space"
Professor Yonghui Zhang
“Development of New Immunotherapies by Targeting Isoprenoid Metabolism”
Programme
09: 00 GMT (5:00 PM CST) – Welcome & introduction09:05 GMT (5:05 PM CST) – "Experimental Structure Property Relationships in the bRo5 space", Nichola Davies (AstraZeneca)
09:30 GMT (5:30 PM CST) – Q&A with Dr Nichola Davies
09:40 GMT (5:40 PM CST) – “Development of New Immunotherapies by Targeting Isoprenoid Metabolism”, Yonghui Zhang (Tsinghua University)
10:05 GMT (6:05 PM CST) – Q&A with Professor Yonghui Zhang
10:15 GMT (6:15 PM CST) – Closing remarks
